SCHEPENS EYE RESEARCH INSTITUTE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 51204
 
  
 
C07K PEPTIDES 16120
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 16151
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 7233
 
  
 
A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES 467
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 445
 
  
 
G06T IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 4131
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
G02C SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES 346
 
  
 
G06K RECOGNITION OF DATA; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS 3195

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0028,598 Compostions for Treating Dry Eye DiseaseJul 10, 17Feb 01, 18[A61K]
2017/0335,280 LOW OXYGEN CULTURE CONDITIONS FOR MAINTAINING RETINAL PROGENITOR CELL MULTIPOTENCYJun 02, 17Nov 23, 17[A61K, C12N]
2017/0198,026 Compositions And Methods For Treating Tumors And Immune Based Inflammatory DiseasesJun 05, 15Jul 13, 17[A61K, C12N, C07K]
2017/0065,168 QUANTIFICATION OF INTER-OCULAR SUPPRESSION IN BINOCULAR VISION IMPAIRMENTNov 18, 16Mar 09, 17[A61B, G02B]
2016/0271,091 Alpha-Aminoadipate For Treatment Of Vision Loss And Restoring SightOct 20, 14Sep 22, 16[A61K]
2016/0212,404 Prevention and Treatment of MyopiaAug 22, 14Jul 21, 16[H04N]
2016/0175,380 Compositions and Methods of Treatment of Corneal Endothelium DisordersDec 31, 15Jun 23, 16[A61K]
2016/0015,783 METHODS FOR MODULATING DEVELOPMENT AND FUNCTION OF PHOTORECEPTOR CELLSMar 03, 14Jan 21, 16[A61K]
2015/0352,131 Compositions and Methods for the Prevention and Treatment of Osteolysis and OsteoporosisJan 16, 14Dec 10, 15[A61K, G01N, A61L]
2015/0246,966 Therapeutic Compositions for the Treatment of Dry Eye DiseaseMar 09, 15Sep 03, 15[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9883793 Spatial modeling of visual fieldsAug 22, 14Feb 06, 18[A61B]
9872901 Therapeutic compositions for treatment of ocular inflammatory disordersMar 07, 16Jan 23, 18[A61K, C07K]
9855314 Methods for modulating development and function of photoreceptor cellsMar 03, 14Jan 02, 18[C07H, A61K, C07K]
9801912 ABCB5(+) stem cells for treating ocular diseaseFeb 19, 14Oct 31, 17[A61K, C12N, A61L]
9730865 Application and uses of PRG4 and therapeutic modulation thereofMay 24, 10Aug 15, 17[A61K, A61B, A61Q, A61L, C07K]
9730978 Compositions for treating dry eye diseaseApr 06, 16Aug 15, 17[A61K, C07K]
9734586 Collision predictionSep 20, 13Aug 15, 17[G06T, G06K]
9719070 Methods of predicting ancestral virus sequences and uses thereofOct 12, 16Aug 01, 17[A61K, C12N, C07K]
9700201 Rapid measurement of visual sensitivityMay 09, 13Jul 11, 17[A61B]
9695220 Methods of predicting ancestral virus sequences and uses thereofApr 11, 16Jul 04, 17[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0095,529 ENDOMUCIN AS AN ANTI-INFLAMMATORY AGENTAbandonedJun 10, 16Apr 06, 17[A61K]
2016/0271,224 METHODS OF REDUCING CORNEAL ENDOTHELIAL CELL LOSSAbandonedNov 20, 14Sep 22, 16[A61K, A61B]
2016/0022,743 HUMAN VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS FOR TREATMENT OF OCULAR DISEASEAbandonedMay 31, 13Jan 28, 16[A61K]
2015/0337,260 Hybrid MatrixAbandonedJan 10, 14Nov 26, 15[A61K, C12N]
2015/0307,619 Use of C-C Chemokine Receptor Type 7 (CCR7) InhibitorsAbandonedDec 13, 13Oct 29, 15[A61K, C07K]
2015/0284,798 Compositions and Methods for the Diagnosis of Retinal NeovascularizationAbandonedOct 14, 13Oct 08, 15[C12Q, C12N, C07K]
2015/0125,432 Human Persistent Fetal Vasculature Neural Progenitors for Transplantation in the Inner RetinaAbandonedMay 10, 13May 07, 15[A61K]
2014/0234,381 SCAFFOLD FOR SUBRETINAL CELL TRANSPLANTATION AND DRUG DELIVERYAbandonedDec 23, 13Aug 21, 14[A61L]
2013/0273,065 Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal TissuesAbandonedMar 12, 13Oct 17, 13[A61K]
2013/0189,341 GENERATION OF PHOTORECEPTORS FROM HUMAN RETINAL PROGENITOR CELLS USING POLYCAPROLACTONE SUBSTRATESAbandonedJan 23, 12Jul 25, 13[A61K, C12Q, A61F, A61P]
2012/0065,518 SYSTEMS AND METHODS FOR MULTILAYER IMAGING AND RETINAL INJURY ANALYSISAbandonedSep 15, 11Mar 15, 12[A61B, G06K]
2012/0014,970 Therapeutic Compositions for Treatment of Corneal DisordersAbandonedJul 14, 11Jan 19, 12[A61K, A61P]
2011/0301,239 USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESISAbandonedApr 27, 09Dec 08, 11[A61K, A61P]
2011/0004,304 CULTURING RETINAL CELLS AND TISSUESAbandonedMar 19, 10Jan 06, 11[A61K, A61F, C12N, C12M, A61P]
2010/0318,193 TOPOGRAPHICALLY ENGINEERED STRUCTURES AND METHODS FOR USING THE SAME IN REGENERATIVE MEDICINE APPLICATIONSAbandonedMar 10, 08Dec 16, 10[A61F]
2010/0105,772 USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESISAbandonedApr 27, 09Apr 29, 10[A61K]
2009/0104,694 ISOLATION AND TRANSPLANTATION OF RETINAL STEM CELLSAbandonedNov 06, 08Apr 23, 09[C12N]
7514259 Isolation and transplantation of retinal stem cellsExpiredFeb 12, 01Apr 07, 09[A01N, C12N]
2008/0153,909 COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS AND CONDITIONSAbandonedOct 17, 07Jun 26, 08[A61K, A61P]
2008/0114,066 Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive FunctionAbandonedJan 15, 08May 15, 08[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.